Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 4:17 pm Sale |
2022-12-31 | 13G | uniQure N.V. QURE |
Point72 Asset Management, L.P. | 1,745,461 3.700% |
-1,866,230 (-51.67%) |
Filing History |
| 2023-02-14 4:16 pm Sale |
2022-12-31 | 13G | TRICIDA INC TCDAQ |
Point72 Asset Management, L.P. | 167,509 0.300% |
-3,117,394 (-94.90%) |
Filing History |
| 2023-02-14 4:15 pm Sale |
2022-12-31 | 13G | Fulcrum Therapeutics, Inc. FULC |
Point72 Asset Management, L.P. | 30,702 0.100% |
-2,037,172 (-98.52%) |
Filing History |
| 2023-02-14 4:14 pm Sale |
2022-12-31 | 13G | Tactile Systems Technology, Inc. TCMD |
Point72 Asset Management, L.P. | 71,124 0.400% |
-1,111,666 (-93.99%) |
Filing History |
| 2023-02-14 4:14 pm Sale |
2022-12-31 | 13G | Esperion Therapeutics, Inc. ESPR |
Point72 Asset Management, L.P. | 2,438,138 4.200% |
-1,032,140 (-29.74%) |
Filing History |
| 2023-02-14 4:13 pm Sale |
2022-12-31 | 13G | Relmada Therapeutics, Inc. RLMD |
Point72 Asset Management, L.P. | 56,207 0.200% |
-2,045,830 (-97.33%) |
Filing History |
| 2023-02-14 4:13 pm Sale |
2022-12-31 | 13G | CytomX Therapeutics, Inc. CTMX |
Point72 Asset Management, L.P. | 0 0.000% |
-6,312,371 (Position Closed) |
Filing History |
| 2023-02-14 4:12 pm Sale |
2022-12-31 | 13G | Chinook Therapeutics, Inc. KDNY |
Point72 Asset Management, L.P. | 1,299,548 2.000% |
-1,817,932 (-58.31%) |
Filing History |
| 2023-02-14 4:12 pm Sale |
2022-12-31 | 13G | Reata Pharmaceuticals, Inc. RETA |
Point72 Asset Management, L.P. | 10,673 0.100% |
-1,653,394 (-99.36%) |
Filing History |
| 2023-02-14 4:11 pm Sale |
2022-12-31 | 13G | Chimerix, Inc. CMRX |
Point72 Asset Management, L.P. | 75,926 0.100% |
-4,472,328 (-98.33%) |
Filing History |
| 2023-02-14 4:11 pm Sale |
2022-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX |
Point72 Asset Management, L.P. | 368,006 0.700% |
-2,052,303 (-84.80%) |
Filing History |
| 2023-02-14 4:10 pm Sale |
2022-12-31 | 13G | Progress Acquisition Corp. PGRW |
Point72 Asset Management, L.P. | 0 0.000% |
-870,229 (Position Closed) |
Filing History |
| 2023-02-14 4:09 pm Sale |
2022-12-31 | 13G | Bicycle Therapeutics plc BCYC |
Point72 Asset Management, L.P. | 1,021,168 3.400% |
-551,655 (-35.07%) |
Filing History |
| 2023-02-14 4:09 pm Sale |
2022-12-31 | 13G | Praxis Precision Medicines, Inc. PRAX |
Point72 Asset Management, L.P. | 73,946 2.200% |
-89,158 (-54.66%) |
Filing History |
| 2023-02-14 4:08 pm Sale |
2022-12-31 | 13G | AxoGen, Inc. AXGN |
Point72 Asset Management, L.P. | 1,864,583 4.400% |
-247,080 (-11.70%) |
Filing History |
| 2023-02-14 4:08 pm Sale |
2022-12-31 | 13G | Oyster Point Pharma, Inc. OYST |
Point72 Asset Management, L.P. | 477 0.100% |
-2,103,725 (-99.98%) |
Filing History |
| 2023-02-14 4:07 pm Purchase |
2022-12-31 | 13G | BellRing Brands, Inc. BRBR |
Point72 Asset Management, L.P. | 2,228,070 1.600% |
2,228,070 (New Position) |
Filing History |
| 2023-02-14 4:06 pm Sale |
2022-12-31 | 13G | Otonomy, Inc. OTIC |
Point72 Asset Management, L.P. | 0 0.000% |
-5,450,000 (Position Closed) |
Filing History |
| 2023-02-14 4:06 pm Sale |
2022-12-31 | 13G | Atara Biotherapeutics, Inc. ATRA |
Point72 Asset Management, L.P. | 8,647 0.200% |
-176,719 (-95.34%) |
Filing History |
| 2023-02-14 4:05 pm Sale |
2022-12-31 | 13G | Minerva Neurosciences, Inc. NERV |
Point72 Asset Management, L.P. | 0 0.000% |
-470,000 (Position Closed) |
Filing History |